Incyte News (NASDAQ:INCY)
| Latest Incyte News Headlines | | Date | Time | Source | | | 11/21/2005 | 6:00AM | PRNUS | Pfizer and Incyte Enter Collaborative Research and License Agreement for the Development and Commercialization of CCR2 Antagonis
Pfizer Gains Worldwide Development and Commercialization Rights Across a Broad Range of Indications
NEW YORK and WILMINGTON, Del., Nov. 21 /PRNewswire-FirstCall/ -- Pfizer Inc, (NYSE:PFE) and Incyte Corporation (NASDAQ:INCY) announced today that the two companies have entered into a global collaborative research and... More...>> |
| 06/02/2004 | 8:01AM | PRNUS | Iconix Announces Chemogenomics Collaborative Relationship with AstraZeneca
Iconix Announces Chemogenomics Collaborative Relationship with
AstraZeneca
MOUNTAIN VIEW, Calif., June 2 /PRNewswire/ -- Iconix Pharmaceuticals, Inc.
today announced that AstraZeneca has selected Iconix to provide advanced
chemogenomic profiling and analytical services for a specific AstraZeneca
Cancer drug discovery... More...>> |
| 05/26/2004 | 1:05PM | PRNUS | Pacific Exchange to Trade Five New Options
Pacific Exchange to Trade Five New Options
SAN FRANCISCO, May 26 /PRNewswire/ -- The Pacific Exchange (PCX) announced
that on Thursday, May 27, 2004, it will begin trading options on Artisan
Components, Inc. (NASDAQ:ARTI)(PCX:ARTI); Incyte Corp. (NASDAQ:INCY)(PCX:INCY);
Novartis AG (NYSE:NVS)(PCX:NVS); Pope & Talbot... More...>> |
| 05/12/2004 | 2:45AM | PRNUS | Ingenium Acquires Pivotal Patents for INGENOtyping(TM) Platform
Ingenium Acquires Pivotal Patents for INGENOtyping(TM) Platform
MUNICH, Germany, May 12 /PRNewswire/ -- Ingenium Pharmaceuticals AG has
acquired outright US patents no. 5,994,075 and no. 6,015,670 from Incyte
Corporation , the company announced today. Ingenium previously maintained a
license to these patents, which... More...>> |
| 02/19/2004 | 9:39AM | PRNUS | MORNING UPDATE: Man Securities Issues Alerts for NXTL, OVTI, PVN, INCY, And OPSW
MORNING UPDATE: Man Securities Issues Alerts for NXTL, OVTI, PVN, INCY, And OPSW
CHICAGO, Feb. 19 /PRNewswire/ -- Man Securities issues the following Morning
Update at 8:30 AM EST with new PriceWatch Alerts for key stocks.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO )
Before the open... PriceWatch... More...>> |
| 02/11/2004 | 9:00PM | PRNUS | Pharmasset Reports Phase 2 HIV Study Results of Reverset(TM): Once-Daily Oral Dose Reduced HIV Viral Load by 1.77 Log(10) copies
Pharmasset Reports Phase 2 HIV Study Results of Reverset(TM): Once-Daily Oral
Dose Reduced HIV Viral Load by 1.77 Log(10) copies/mL
ATLANTA, Feb. 11 /PRNewswire/ -- Pharmasset, Inc. today announced results from
a Phase 2 study of Reverset, which is being co-developed with Incyte Corporation
for the treatment of HIV-infected... More...>> |
| 11/24/2003 | 8:00AM | PRNUS | Iconix Enters Relationship with Eli Lilly and Company
Iconix Enters Relationship with Eli Lilly and Company
MOUNTAIN VIEW, Calif., Nov. 24 /PRNewswire/ -- Iconix Pharmaceuticals, Inc.
today announced that Eli Lilly and Company has selected Iconix to provide
advanced chemogenomics profiling and analytical services.
"The use of chemogenomics supports increased productivity... More...>> |
| 10/29/2003 | 8:01AM | PRNUS | Iconix Releases Updated Version 2.30 of DrugMatrix(TM) World's Largest Chemogenomics Reference Database & Informatics System
Iconix Releases Updated Version 2.30 of DrugMatrix(TM) World's Largest
Chemogenomics Reference Database & Informatics System
MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire/ -- Iconix Pharmaceuticals, Inc.
today announced the release of an updated version 2.30 of DrugMatrix(TM), the
world's largest chemogenomics reference... More...>> |
|
|
|